Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8789918 | Urologic Oncology: Seminars and Original Investigations | 2018 | 7 Pages |
Abstract
In this study, perioperative ABTs were independently associated with worse oncological outcomes in patients with clinically localized RCC. Receipt of ABT was associated with roughly a 2-fold increase in the hazard of metastatic progression, all-cause and RCC-specific mortality. Further research is needed on the mechanisms of transfusion-induced immunomodulation, alternative transfusion protocols and methods for autologous blood transfusion and recovery.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Matvey M.D., Michael R. M.D., Efrat M.D., Christina B.S., Ghalib M.D., Edward N. M.D., Thomas J. M.D.,